244 related articles for article (PubMed ID: 32471179)
1. Sevelamer Use in End-Stage Kidney Disease (ESKD) Patients Associates with Poor Vitamin K Status and High Levels of Gut-Derived Uremic Toxins: A Drug-Bug Interaction?
Dai L; Meijers BK; Bammens B; de Loor H; Schurgers LJ; Qureshi AR; Stenvinkel P; Evenepoel P
Toxins (Basel); 2020 May; 12(6):. PubMed ID: 32471179
[TBL] [Abstract][Full Text] [Related]
2. The role of kidney transplantation and phosphate binder use in vitamin K status.
Jansz TT; Neradova A; van Ballegooijen AJ; Verhaar MC; Vervloet MG; Schurgers LJ; van Jaarsveld BC
PLoS One; 2018; 13(8):e0203157. PubMed ID: 30161193
[TBL] [Abstract][Full Text] [Related]
3. The Effect of Sevelamer on Serum Levels of Gut-Derived Uremic Toxins: Results from In Vitro Experiments and A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
Bennis Y; Cluet Y; Titeca-Beauport D; El Esper N; Ureña P; Bodeau S; Combe C; Dussol B; Fouque D; Choukroun G; Liabeuf S
Toxins (Basel); 2019 May; 11(5):. PubMed ID: 31109001
[TBL] [Abstract][Full Text] [Related]
4. Hepatic and Vascular Vitamin K Status in Patients with High Cardiovascular Risk.
Rapp N; Brandenburg VM; Kaesler N; Bakker SJL; Stöhr R; Schuh A; Evenepoel P; Schurgers LJ
Nutrients; 2021 Oct; 13(10):. PubMed ID: 34684491
[TBL] [Abstract][Full Text] [Related]
5. Vitamin K status and mortality after kidney transplantation: a cohort study.
Keyzer CA; Vermeer C; Joosten MM; Knapen MH; Drummen NE; Navis G; Bakker SJ; de Borst MH
Am J Kidney Dis; 2015 Mar; 65(3):474-83. PubMed ID: 25453995
[TBL] [Abstract][Full Text] [Related]
6. Gut-Derived Metabolites and Their Role in Immune Dysfunction in Chronic Kidney Disease.
Glorieux G; Gryp T; Perna A
Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32290429
[TBL] [Abstract][Full Text] [Related]
7. Does the Administration of Sevelamer or Nicotinamide Modify Uremic Toxins or Endotoxemia in Chronic Hemodialysis Patients?
Lenglet A; Fabresse N; Taupin M; Gomila C; Liabeuf S; Kamel S; Alvarez JC; Drueke TB; Massy ZA
Drugs; 2019 Jun; 79(8):855-862. PubMed ID: 31062264
[TBL] [Abstract][Full Text] [Related]
8. Uncarboxylated matrix Gla-protein: A biomarker of vitamin K status and cardiovascular risk.
Jespersen T; Møllehave LT; Thuesen BH; Skaaby T; Rossing P; Toft U; Jørgensen NR; Corfixen BL; Jakobsen J; Frimodt-Møller M; Linneberg A
Clin Biochem; 2020 Sep; 83():49-56. PubMed ID: 32422228
[TBL] [Abstract][Full Text] [Related]
9. Pleiotropic effects of the non-calcium phosphate binder sevelamer.
Nikolov IG; Joki N; Maizel J; Lacour B; Drüeke TB; Massy ZA
Kidney Int Suppl; 2006 Dec; (105):S16-23. PubMed ID: 17136111
[TBL] [Abstract][Full Text] [Related]
10. Associations of vitamin K status with mortality and cardiovascular events in peritoneal dialysis patients.
Xu Q; Guo H; Cao S; Zhou Q; Chen J; Su M; Chen S; Jiang S; Shi X; Wen Y
Int Urol Nephrol; 2019 Mar; 51(3):527-534. PubMed ID: 30689181
[TBL] [Abstract][Full Text] [Related]
11. Uremic toxins and oral adsorbents.
Goto S; Yoshiya K; Kita T; Fujii H; Fukagawa M
Ther Apher Dial; 2011 Apr; 15(2):132-4. PubMed ID: 21426503
[TBL] [Abstract][Full Text] [Related]
12. Vitamin k intake and plasma desphospho-uncarboxylated matrix Gla-protein levels in kidney transplant recipients.
Boxma PY; van den Berg E; Geleijnse JM; Laverman GD; Schurgers LJ; Vermeer C; Kema IP; Muskiet FA; Navis G; Bakker SJ; de Borst MH
PLoS One; 2012; 7(10):e47991. PubMed ID: 23118917
[TBL] [Abstract][Full Text] [Related]
13. Kidney Function-Dependence of Vitamin K-Status Parameters: Results from the TransplantLines Biobank and Cohort Studies.
Kremer D; Groothof D; Keyzer CA; Eelderink C; Knobbe TJ; Post A; van Londen M; Eisenga MF; TransplantLines Investigators ; Schurgers LJ; Berger SP; de Borst MH; Bakker SJL
Nutrients; 2021 Aug; 13(9):. PubMed ID: 34578950
[TBL] [Abstract][Full Text] [Related]
14. Poor Vitamin K Status Is Associated With Low Bone Mineral Density and Increased Fracture Risk in End-Stage Renal Disease.
Evenepoel P; Claes K; Meijers B; Laurent M; Bammens B; Naesens M; Sprangers B; Pottel H; Cavalier E; Kuypers D
J Bone Miner Res; 2019 Feb; 34(2):262-269. PubMed ID: 30427544
[TBL] [Abstract][Full Text] [Related]
15. Gut Microbiome-Derived Uremic Toxin Levels in Hemodialysis Patients on Different Phosphate Binder Therapies.
Wang LC; Tapia LM; Tao X; Chao JE; Thwin O; Zhang H; Thijssen S; Kotanko P; Grobe N
Blood Purif; 2022; 51(8):639-648. PubMed ID: 34375976
[TBL] [Abstract][Full Text] [Related]
16. Emerging drugs for hyperphosphatemia.
Bellinghieri G; Santoro D; Savica V
Expert Opin Emerg Drugs; 2007 Sep; 12(3):355-65. PubMed ID: 17874966
[TBL] [Abstract][Full Text] [Related]
17. High Dephosphorylated-Uncarboxylated MGP in Hemodialysis patients: risk factors and response to vitamin K
Aoun M; Makki M; Azar H; Matta H; Chelala DN
BMC Nephrol; 2017 Jun; 18(1):191. PubMed ID: 28592319
[TBL] [Abstract][Full Text] [Related]
18. Circulating uncarboxylated matrix Gla protein, a marker of vitamin K status, as a risk factor of cardiovascular disease.
van den Heuvel EG; van Schoor NM; Lips P; Magdeleyns EJ; Deeg DJ; Vermeer C; den Heijer M
Maturitas; 2014 Feb; 77(2):137-41. PubMed ID: 24210635
[TBL] [Abstract][Full Text] [Related]
19. Microbiome perturbation by oral vancomycin reduces plasma concentration of two gut-derived uremic solutes, indoxyl sulfate and p-cresyl sulfate, in end-stage renal disease.
Nazzal L; Roberts J; Singh P; Jhawar S; Matalon A; Gao Z; Holzman R; Liebes L; Blaser MJ; Lowenstein J
Nephrol Dial Transplant; 2017 Nov; 32(11):1809-1817. PubMed ID: 28379433
[TBL] [Abstract][Full Text] [Related]
20. Thrombolome and Its Emerging Role in Chronic Kidney Diseases.
Fryc J; Naumnik B
Toxins (Basel); 2021 Mar; 13(3):. PubMed ID: 33803899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
